HIV Care: Translating Science Into Practice
Blog updated 03/28/2024
Blog updated 03/28/2024
Overview of Medicare eligibility and coverage for RWHAP clients and other people with HIV.
Resource updated 09/25/2023
Overview of Medicare prescription drug coverage for RWHAP clients and other people with HIV.
Resource updated 11/02/2023
Overview of Medicare eligibility and coverage for RWHAP clients and other people with HIV.
Resource updated 09/19/2023
Explanation of Medicare (and its Parts) for consumers as they contemplate enrollment.
Resource updated 10/04/2023
Resource updated 09/25/2023
Resource updated 10/04/2023
RWHAP Technical Assistance Provider updated on 03/05/2024
Update to the Unmet Need Methodology for RWHAP Part A and B recipients.
Resource updated 09/19/2023
Excel files for calculating unmet need estimates.
Resource updated 09/19/2023
This infographic provides a high-level workflow for RWHAP recipients completing the required and enhanced and Unmet Need Estimates and Analyses.
Resource updated 09/19/2023
Answers to common questions about Estimating Unmet Need. These FAQs have been generated in response to questions from RWHAP recipients who attended webinars and/or received TA on Estimating Unmet Need.
Resource updated 09/19/2023
Webinars and other special events by HRSA's HIV/AIDS Bureau.
Resource updated 01/09/2024
Resource updated 09/19/2023
Resource updated 10/26/2021
Resource updated 05/18/2021
As HIV elimination activities increase, jurisdictions can address HIV/Hepatitis C (HCV) co-infection by enhancing HCV screening and treatment data collection. This session will discuss NASTAD's work with North Carolina to incorporate HCV data in CAREWare and electronic health records (EHRs), as well as recommendations for integrating HCV services into the HIV care infrastructure.
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Learn how to develop, plan, and implement an organization-wide ECHO model to fully integrate HIV/HCV care and treatment into primary care centers and create wider access for patients with less barriers to care.
Resource (Conference Presentation) updated 09/14/2023
Among people with HIV who also inject drugs, an estimated 80 to 90 percent are coinfected with Hepatitis C (HCV.) This panel will provide updates on screening and referral activities and demonstrate how community and city partners are overcoming barriers to HCV care among PWID.
Resource (Conference Presentation) updated 09/14/2023